Výsledky vyhledávání - "Camilla Darum Sørensen"

Complete donor chimerism following 0/10 HLA-mismatched unrelated donor allogeneic hematopoietic stem cell transplantation

Autor: Bjarne Kuno Møller, Camilla Darum Sørensen, Peter Hokland, Gitte Olesen, Marianne Hokland

Publikováno v: Sørensen, C D, Møller, B K, Olesen, G, Hokland, P & Hokland, M 2018, ' Complete donor chimerism following 0/10 HLA-mismatched unrelated donor allogeneic hematopoietic stem cell transplantation ', Bone Marrow Transplantation, vol. 53, pp. 1578-1582 . https://doi.org/10.1038/s41409-018-0229-y

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::594175ab506fefdbab03eaec643fa3af
https://doi.org/10.1038/s41409-018-0229-y

Zobrazit plný text záznamu

SOX11, CCND1, BCL1/IgH and IgH-VDJ: a battle of minimal residual disease markers in mantle cell lymphoma

Autor: Camilla Darum Sørensen, Charlotte Guldborg Nyvold, Anita Tranberg Simonsen, Marie Schou, Hans Bentzen

Publikováno v: Simonsen, A T, Schou, M, Sørensen, C D, Bentzen, H H N & Nyvold, C G 2015, ' SOX11, CCND1, BCL1/IgH and IgH-VDJ: a battle of minimal residual disease markers in mantle cell lymphoma ', Leukemia and Lymphoma, vol. 56, no. 9, pp. 2724-2727 . https://doi.org/10.3109/10428194.2015.1004672

Minimal residual disease (MRD) is defined as the persistence of residual tumor cells in patients during or after treatment, when the patient is in remission. The monitoring of MRD has been shown to...

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::43c56cac5eb18fb791339fa41e69f464
https://pure.au.dk/portal/da/publications/sox11-ccnd1-bcl1igh-and-ighvdj-a-battle-of-minimal-residual-disease-markers-in-mantle-cell-lymphoma(2f820495-afe3-45ec-853f-8bf2a840005d).html

Zobrazit plný text záznamu

SOX11 as a minimal residual disease marker for Mantle cell lymphoma

Autor: Lene Hyldahl Ebbesen, Anita Tranberg Simonsen, Julie Støve Bødker, Charlotte Guldborg Nyvold, Hans Bentzen, Camilla Darum Sørensen

Publikováno v: Simonsen, A T, Sørensen, C D, Ebbesen, L H, Bødker, J S, Bentzen, H H N & Nyvold, C G 2014, ' SOX11 as a minimal residual disease marker for Mantle cell lymphoma ', Leukemia Research, vol. 38, no. 8, pp. 918-24 . https://doi.org/10.1016/j.leukres.2014.04.007
Simonsen, A T, Sørensen, C D, Ebbesen, L H, Bødker, J S, Bentzen, H H N & Nyvold, C G 2014, ' SOX11 as a minimal residual disease marker for Mantle cell lymphoma ', Leukemia Research, vol. 38, no. 8, pp. 918-924 . https://doi.org/10.1016/j.leukres.2014.04.007

Recent studies have identified SOX11 as a novel diagnostic marker for mantle cell lymphoma (MCL). We quantified SOX11 by a truly mRNA specific qPCR assay in longitudinal peripheral blood samples from 20 patients and evidenced a close relationship of

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0565b20598b488241f66020481ea38a1
https://pure.au.dk/portal/da/publications/sox11-as-a-minimal-residual-disease-marker-for-mantle-cell-lymphoma(0e6485e4-1a78-4637-a71a-75b4f233b9b8).html

Zobrazit plný text záznamu

Common consensus LNA probe for quantitative PCR assays in cancer: Vehicles for minimal residual disease detection in t(11;14) and t(14;18) positive malignant lymphomas

Autor: Judit Jørgensen, Line Nederby, Peter Hokland, Camilla Darum Sørensen, Charlotte Guldborg Nyvold

Publikováno v: Sørensen, C D, Jørgensen, J M, Nederby, L, Hokland, P & Nyvold, C G 2014, ' Common consensus LNA probe for quantitative PCR assays in cancer: Vehicles for minimal residual disease detection in t(11;14) and t(14;18) positive malignant lymphomas ', Journal of Immunological Methods, vol. 406, pp. 131-136 . https://doi.org/10.1016/j.jim.2014.03.004
Sørensen, C D, Jørgensen, J M, Nederby, L, Hokland, P & Nyvold, C G 2014, ' Common consensus LNA probe for quantitative PCR assays in cancer : Vehicles for minimal residual disease detection in t(11;14) and t(14;18) positive malignant lymphomas ', Journal of Immunological Methods, vol. 406, pp. 131-136 . https://doi.org/10.1016/j.jim.2014.03.004

The use of locked nucleic acid (LNA) probes and primers potentially improves sensitivity and specificity of quantitative PCR (qPCR) assays. One area of application is that of minimal residual cancer where PCR techniques have proved to be highly relev

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1ab965d54f077f62e4cc6dc8dfdd6011
https://portal.findresearcher.sdu.dk/da/publications/56bfdd81-f072-438f-8c10-77dcbf171dfa

Zobrazit plný text záznamu

Potent microRNA suppression by RNA Pol II-transcribed 'Tough Decoy' inhibitors

Autor: Anne Kruse Hollensen, Rasmus O. Bak, Maria Nascimento Primo, Jacob Giehm Mikkelsen, Camilla Darum Sørensen

Publikováno v: Bak, R O, Hollensen, A K, Primo, M N, Sørensen, C D & Mikkelsen, J G 2013, ' Potent microRNA suppression by RNA Pol II-transcribed 'Tough Decoy' inhibitors ', RNA, vol. 19, no. 2, pp. 280-293 . https://doi.org/10.1261/rna.034850.112

MicroRNAs (miRNAs) are key regulators of gene expression and modulators of diverse biological pathways. Analyses of miRNA function as well as therapeutic managing of miRNAs rely on cellular administration of miRNA inhibitors which may be achieved by

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f1542f4c46c00863a8e4328844a8bccf
https://pubmed.ncbi.nlm.nih.gov/23249752

Zobrazit plný text záznamu

SOX11, CCND1, BCL1/Igh, and Igh-VDJ – a Plethora of Markers for Minimal Residual Disease in Mantle Cell Lymphoma: Which One to Choose?

Autor: Charlotte Guldborg Nyvold, Marie Schou, Anita Tranberg Simonsen, Camilla Darum Sørensen, Peter Hokland, Hans Bentzen

Publikováno v: Blood. 124:2957-2957

INTRODUCTION: Minimal residual disease (MRD) is defined as the persistence of residual tumor cells in patients during or after treatment, when the patient is in remission. The monitoring of MRD has been shown to be an excellent tool for optimization

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::a254a1ad34c5af504b7c9a6e02f87778
https://doi.org/10.1182/blood.v124.21.2957.2957

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání